| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 2 |
| GO:0005654 | nucleoplasm | 2 | 2 |
| GO:0005685 | U1 snRNP | 5 | 2 |
| GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 2 |
| GO:0032991 | protein-containing complex | 1 | 2 |
| GO:0043226 | organelle | 2 | 2 |
| GO:0043227 | membrane-bounded organelle | 3 | 2 |
| GO:0043229 | intracellular organelle | 3 | 2 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
| GO:0097525 | spliceosomal snRNP complex | 4 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0120114 | Sm-like protein family complex | 2 | 2 |
| GO:0140513 | nuclear protein-containing complex | 2 | 2 |
| GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Related structures:
AlphaFold database: Q4Q9U8
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000375 | RNA splicing, via transesterification reactions | 8 | 2 |
| GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 2 |
| GO:0000398 | mRNA splicing, via spliceosome | 8 | 2 |
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
| GO:0006396 | RNA processing | 6 | 2 |
| GO:0006397 | mRNA processing | 7 | 2 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0008380 | RNA splicing | 7 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0016070 | RNA metabolic process | 5 | 2 |
| GO:0016071 | mRNA metabolic process | 6 | 2 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
| GO:0043170 | macromolecule metabolic process | 3 | 2 |
| GO:0044237 | cellular metabolic process | 2 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0045292 | mRNA cis splicing, via spliceosome | 9 | 2 |
| GO:0046483 | heterocycle metabolic process | 3 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:0090304 | nucleic acid metabolic process | 4 | 2 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.499 |
| CLV_NRD_NRD_1 | 217 | 219 | PF00675 | 0.517 |
| CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.351 |
| CLV_NRD_NRD_1 | 83 | 85 | PF00675 | 0.630 |
| CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.552 |
| CLV_PCSK_KEX2_1 | 217 | 219 | PF00082 | 0.517 |
| CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.404 |
| CLV_PCSK_KEX2_1 | 82 | 84 | PF00082 | 0.628 |
| CLV_PCSK_PC1ET2_1 | 117 | 119 | PF00082 | 0.595 |
| CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.548 |
| CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.428 |
| DOC_CKS1_1 | 154 | 159 | PF01111 | 0.348 |
| DOC_CYCLIN_yCln2_LP_2 | 75 | 81 | PF00134 | 0.631 |
| DOC_MAPK_DCC_7 | 99 | 108 | PF00069 | 0.517 |
| DOC_MAPK_JIP1_4 | 196 | 202 | PF00069 | 0.471 |
| DOC_MAPK_MEF2A_6 | 196 | 204 | PF00069 | 0.469 |
| DOC_PP1_RVXF_1 | 82 | 89 | PF00149 | 0.595 |
| DOC_USP7_MATH_1 | 61 | 65 | PF00917 | 0.627 |
| DOC_WW_Pin1_4 | 122 | 127 | PF00397 | 0.621 |
| DOC_WW_Pin1_4 | 153 | 158 | PF00397 | 0.342 |
| LIG_14-3-3_CanoR_1 | 118 | 126 | PF00244 | 0.544 |
| LIG_14-3-3_CanoR_1 | 191 | 200 | PF00244 | 0.552 |
| LIG_14-3-3_CanoR_1 | 217 | 224 | PF00244 | 0.555 |
| LIG_14-3-3_CanoR_1 | 82 | 87 | PF00244 | 0.738 |
| LIG_CtBP_PxDLS_1 | 105 | 109 | PF00389 | 0.459 |
| LIG_deltaCOP1_diTrp_1 | 242 | 248 | PF00928 | 0.505 |
| LIG_eIF4E_1 | 69 | 75 | PF01652 | 0.595 |
| LIG_FHA_1 | 217 | 223 | PF00498 | 0.579 |
| LIG_FHA_2 | 209 | 215 | PF00498 | 0.478 |
| LIG_LIR_Gen_1 | 30 | 36 | PF02991 | 0.341 |
| LIG_LIR_Gen_1 | 85 | 96 | PF02991 | 0.584 |
| LIG_LIR_Nem_3 | 12 | 17 | PF02991 | 0.446 |
| LIG_LIR_Nem_3 | 30 | 34 | PF02991 | 0.233 |
| LIG_LIR_Nem_3 | 85 | 91 | PF02991 | 0.639 |
| LIG_MYND_1 | 101 | 105 | PF01753 | 0.508 |
| LIG_PCNA_yPIPBox_3 | 68 | 82 | PF02747 | 0.645 |
| LIG_SH2_CRK | 14 | 18 | PF00017 | 0.421 |
| LIG_SH2_GRB2like | 201 | 204 | PF00017 | 0.497 |
| LIG_SH2_SRC | 147 | 150 | PF00017 | 0.378 |
| LIG_SH2_SRC | 176 | 179 | PF00017 | 0.420 |
| LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.510 |
| LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.354 |
| LIG_SH2_STAT5 | 16 | 19 | PF00017 | 0.405 |
| LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.393 |
| LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.497 |
| LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.582 |
| LIG_SH3_3 | 154 | 160 | PF00018 | 0.347 |
| LIG_SH3_3 | 184 | 190 | PF00018 | 0.550 |
| LIG_SH3_3 | 30 | 36 | PF00018 | 0.460 |
| LIG_SUMO_SIM_anti_2 | 167 | 173 | PF11976 | 0.456 |
| LIG_TRAF2_1 | 211 | 214 | PF00917 | 0.506 |
| LIG_TRAF2_1 | 236 | 239 | PF00917 | 0.632 |
| LIG_TYR_ITIM | 199 | 204 | PF00017 | 0.498 |
| LIG_WRC_WIRS_1 | 223 | 228 | PF05994 | 0.551 |
| LIG_WRC_WIRS_1 | 93 | 98 | PF05994 | 0.696 |
| LIG_WW_3 | 188 | 192 | PF00397 | 0.562 |
| MOD_CDK_SPxK_1 | 153 | 159 | PF00069 | 0.467 |
| MOD_CK1_1 | 122 | 128 | PF00069 | 0.492 |
| MOD_CK1_1 | 225 | 231 | PF00069 | 0.687 |
| MOD_CK1_1 | 60 | 66 | PF00069 | 0.572 |
| MOD_CK1_1 | 95 | 101 | PF00069 | 0.525 |
| MOD_CK2_1 | 130 | 136 | PF00069 | 0.522 |
| MOD_CK2_1 | 208 | 214 | PF00069 | 0.494 |
| MOD_CK2_1 | 232 | 238 | PF00069 | 0.641 |
| MOD_CK2_1 | 45 | 51 | PF00069 | 0.530 |
| MOD_CMANNOS | 245 | 248 | PF00535 | 0.497 |
| MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.617 |
| MOD_GlcNHglycan | 191 | 194 | PF01048 | 0.555 |
| MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.566 |
| MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.570 |
| MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.668 |
| MOD_GSK3_1 | 122 | 129 | PF00069 | 0.648 |
| MOD_GSK3_1 | 222 | 229 | PF00069 | 0.632 |
| MOD_GSK3_1 | 45 | 52 | PF00069 | 0.570 |
| MOD_GSK3_1 | 57 | 64 | PF00069 | 0.579 |
| MOD_NEK2_1 | 226 | 231 | PF00069 | 0.562 |
| MOD_NEK2_1 | 250 | 255 | PF00069 | 0.518 |
| MOD_PIKK_1 | 191 | 197 | PF00454 | 0.502 |
| MOD_PIKK_1 | 253 | 259 | PF00454 | 0.527 |
| MOD_PIKK_1 | 69 | 75 | PF00454 | 0.553 |
| MOD_PK_1 | 130 | 136 | PF00069 | 0.603 |
| MOD_PKA_1 | 217 | 223 | PF00069 | 0.548 |
| MOD_PKA_1 | 82 | 88 | PF00069 | 0.594 |
| MOD_PKA_2 | 129 | 135 | PF00069 | 0.660 |
| MOD_PKA_2 | 216 | 222 | PF00069 | 0.538 |
| MOD_PKA_2 | 250 | 256 | PF00069 | 0.645 |
| MOD_PKA_2 | 82 | 88 | PF00069 | 0.594 |
| MOD_Plk_1 | 130 | 136 | PF00069 | 0.651 |
| MOD_Plk_4 | 6 | 12 | PF00069 | 0.488 |
| MOD_Plk_4 | 61 | 67 | PF00069 | 0.612 |
| MOD_ProDKin_1 | 122 | 128 | PF00069 | 0.623 |
| MOD_ProDKin_1 | 153 | 159 | PF00069 | 0.351 |
| TRG_DiLeu_BaLyEn_6 | 42 | 47 | PF01217 | 0.389 |
| TRG_ENDOCYTIC_2 | 14 | 17 | PF00928 | 0.415 |
| TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.413 |
| TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.497 |
| TRG_ER_diArg_1 | 116 | 119 | PF00400 | 0.543 |
| TRG_ER_diArg_1 | 216 | 218 | PF00400 | 0.525 |
| TRG_ER_diArg_1 | 81 | 84 | PF00400 | 0.629 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PDN1 | Leptomonas seymouri | 56% | 100% |
| A0A1X0NM21 | Trypanosomatidae | 27% | 100% |
| A0A3S5H7E8 | Leishmania donovani | 94% | 100% |
| A4HE80 | Leishmania braziliensis | 88% | 100% |
| A4I1I9 | Leishmania infantum | 94% | 100% |
| C9ZJX7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
| E9AXM4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
| V5BCP1 | Trypanosoma cruzi | 26% | 100% |